[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Meropenem Market Report 2016

September 2016 | 110 pages | ID: U5E6234306FEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Meropenem

Revenue, means the sales value of Meropenem

This report studies sales (consumption) of Meropenem in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer
  • Shenzhen Haibin Pharmaceutical
  • Novartis
  • Mylan
  • GE Healthcare
  • Spectrum Chemical Manufacturing Corp
  • Abbott
  • Takeda
  • Hisun-Pfizer Pharmaceuticals
  • Haikou Pharmaceutical Factory
  • Shijiazhuang Pharma
  • Sumitomo Pharmaceuticals
  • Sumitomo Dainippon Pharma Co.,Ltd
  • Varika Chemicals & Pharmaceuticals Ltd
  • Astra Zeneca Pharma India Limited
  • Crucell Switzerland AG
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Injection
  • Freeze-dried powder
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Meropenem in each application, can be divided into
  • Hospital use
  • Clinic
  • Others
United States Meropenem Market Report 2016

1 MEROPENEM OVERVIEW

1.1 Product Overview and Scope of Meropenem
1.2 Classification of Meropenem
  1.2.11 Injection
  1.2.12 Freeze-dried powder
  1.2.3 Type III
1.3 Application of Meropenem
  1.3.11 Hospital use
  1.3.12 Clinic
  1.3.13 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meropenem (2011-2021)
  1.4.1 United States Meropenem Sales and Growth Rate (2011-2021)
  1.4.2 United States Meropenem Revenue and Growth Rate (2011-2021)

2 UNITED STATES MEROPENEM COMPETITION BY MANUFACTURERS

2.1 United States Meropenem Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meropenem Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meropenem Average Price by Manufactures (2015 and 2016)
2.4 Meropenem Market Competitive Situation and Trends
  2.4.1 Meropenem Market Concentration Rate
  2.4.2 Meropenem Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MEROPENEM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Meropenem Sales and Market Share by Type (2011-2016)
3.2 United States Meropenem Revenue and Market Share by Type (2011-2016)
3.3 United States Meropenem Price by Type (2011-2016)
3.4 United States Meropenem Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MEROPENEM SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Meropenem Sales and Market Share by Application (2011-2016)
4.2 United States Meropenem Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MEROPENEM MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meropenem Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Shenzhen Haibin Pharmaceutical
  5.2.2 Meropenem Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Shenzhen Haibin Pharmaceutical Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Novartis
  5.3.2 Meropenem Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Novartis Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Mylan
  5.4.2 Meropenem Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Mylan Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 GE Healthcare
  5.5.2 Meropenem Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 GE Healthcare Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Spectrum Chemical Manufacturing Corp
  5.6.2 Meropenem Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Spectrum Chemical Manufacturing Corp Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Abbott
  5.7.2 Meropenem Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Abbott Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Takeda
  5.8.2 Meropenem Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Takeda Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Hisun-Pfizer Pharmaceuticals
  5.9.2 Meropenem Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Hisun-Pfizer Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Haikou Pharmaceutical Factory
  5.10.2 Meropenem Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Haikou Pharmaceutical Factory Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Shijiazhuang Pharma
5.12 Sumitomo Pharmaceuticals
5.13 Sumitomo Dainippon Pharma Co.,Ltd
5.14 Varika Chemicals & Pharmaceuticals Ltd
5.15 Astra Zeneca Pharma India Limited
5.16 Crucell Switzerland AG

6 MEROPENEM MANUFACTURING COST ANALYSIS

6.1 Meropenem Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meropenem

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meropenem Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meropenem Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MEROPENEM MARKET FORECAST (2016-2021)

10.1 United States Meropenem Sales, Revenue Forecast (2016-2021)
10.2 United States Meropenem Sales Forecast by Type (2016-2021)
10.3 United States Meropenem Sales Forecast by Application (2016-2021)
10.4 Meropenem Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Meropenem
Table Classification of Meropenem
Figure United States Sales Market Share of Meropenem by Type in 2015
Figure Injection Picture
Figure Freeze-dried powder Picture
Table Application of Meropenem
Figure United States Sales Market Share of Meropenem by Application in 2015
Figure Hospital use Examples
Figure Clinic Examples
Figure Others Examples
Figure United States Meropenem Sales and Growth Rate (2011-2021)
Figure United States Meropenem Revenue and Growth Rate (2011-2021)
Table United States Meropenem Sales of Key Manufacturers (2015 and 2016)
Table United States Meropenem Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meropenem Sales Share by Manufacturers
Figure 2016 Meropenem Sales Share by Manufacturers
Table United States Meropenem Revenue by Manufacturers (2015 and 2016)
Table United States Meropenem Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Meropenem Revenue Share by Manufacturers
Table 2016 United States Meropenem Revenue Share by Manufacturers
Table United States Market Meropenem Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Meropenem Average Price of Key Manufacturers in 2015
Figure Meropenem Market Share of Top 3 Manufacturers
Figure Meropenem Market Share of Top 5 Manufacturers
Table United States Meropenem Sales by Type (2011-2016)
Table United States Meropenem Sales Share by Type (2011-2016)
Figure United States Meropenem Sales Market Share by Type in 2015
Table United States Meropenem Revenue and Market Share by Type (2011-2016)
Table United States Meropenem Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meropenem by Type (2011-2016)
Table United States Meropenem Price by Type (2011-2016)
Figure United States Meropenem Sales Growth Rate by Type (2011-2016)
Table United States Meropenem Sales by Application (2011-2016)
Table United States Meropenem Sales Market Share by Application (2011-2016)
Figure United States Meropenem Sales Market Share by Application in 2015
Table United States Meropenem Sales Growth Rate by Application (2011-2016)
Figure United States Meropenem Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Meropenem Sales Market Share (2011-2016)
Table Shenzhen Haibin Pharmaceutical Basic Information List
Table Shenzhen Haibin Pharmaceutical Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shenzhen Haibin Pharmaceutical Meropenem Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Meropenem Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Meropenem Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Meropenem Sales Market Share (2011-2016)
Table Spectrum Chemical Manufacturing Corp Basic Information List
Table Spectrum Chemical Manufacturing Corp Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Chemical Manufacturing Corp Meropenem Sales Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Meropenem Sales Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Meropenem Sales Market Share (2011-2016)
Table Hisun-Pfizer Pharmaceuticals Basic Information List
Table Hisun-Pfizer Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hisun-Pfizer Pharmaceuticals Meropenem Sales Market Share (2011-2016)
Table Haikou Pharmaceutical Factory Basic Information List
Table Haikou Pharmaceutical Factory Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Haikou Pharmaceutical Factory Meropenem Sales Market Share (2011-2016)
Table Shijiazhuang Pharma Basic Information List
Table Shijiazhuang Pharma Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shijiazhuang Pharma Meropenem Sales Market Share (2011-2016)
Table Sumitomo Pharmaceuticals Basic Information List
Table Sumitomo Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Pharmaceuticals Meropenem Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Co.,Ltd Basic Information List
Table Sumitomo Dainippon Pharma Co.,Ltd Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Co.,Ltd Meropenem Sales Market Share (2011-2016)
Table Varika Chemicals & Pharmaceuticals Ltd Basic Information List
Table Varika Chemicals & Pharmaceuticals Ltd Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Varika Chemicals & Pharmaceuticals Ltd Meropenem Sales Market Share (2011-2016)
Table Astra Zeneca Pharma India Limited Basic Information List
Table Astra Zeneca Pharma India Limited Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Pharma India Limited Meropenem Sales Market Share (2011-2016)
Table Crucell Switzerland AG Basic Information List
Table Crucell Switzerland AG Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Crucell Switzerland AG Meropenem Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meropenem
Figure Manufacturing Process Analysis of Meropenem
Figure Meropenem Industrial Chain Analysis
Table Raw Materials Sources of Meropenem Major Manufacturers in 2015
Table Major Buyers of Meropenem
Table Distributors/Traders List
Figure United States Meropenem Production and Growth Rate Forecast (2016-2021)
Figure United States Meropenem Revenue and Growth Rate Forecast (2016-2021)
Table United States Meropenem Production Forecast by Type (2016-2021)
Table United States Meropenem Consumption Forecast by Application (2016-2021)


More Publications